Department of Breast Surgery, Yantai Yuhuangding Hospital
Department of Breast Surgery, Yantai Yuhuangding Hospital
Yantai, Shandong, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for Neoadjuvant Treatment of Triple-Negative Breast Cancer (TNBC) | Neoadjuvant Therapy; Stage II to III (T1cN1-2 or T2-4N0-2) TNBC Breast Cancer | Not yet recruiting | Phase 2 | 2025-10-01 | NCT07054242 |